[ET Net News Agency, 13 March 2024] KEYMED BIO-B (02162) rose 10.8% to HK$39.5.
It hits an intra-day high of HK$39.5, hitting an 1-month high, and an intra-day low of
HK$34.85. The total shares traded was 2.24 million, with a value of HK$81.86m. The active
buy/sell ratio is 61:39, with net buying turnover of HK$17.03m. CHINA INNOVATION MARKET
SER accounts for greatest net responsive buying turnover of HK$3.39m, with volume weighted
average price of HK$36.335. BARCLAYS CAPITAL ASIA accounts for greatest net responsive
selling turnover of HK$7.15m, with volume weighted average price of HK$36.594. The stock
has risen a combined 30.6% over the past 4 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 39.500 % Chg +10.80%
High 39.500 Low 34.850
Shares Tr 2.24m Turnover 81.86m
10-D SMA 33.940 %H.V 76.870
20-D SMA 33.495 VWAP 36.514
50-D SMA 35.005 RSI14 62.841
----------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 61:39, with net buying turnover
of HK$17.03m, rising a combined 30.6% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 39.50 +10.80
HUTCHMED (00013) 27.60 +8.66
GENSCRIPT BIO (01548) 17.08 +8.79
INNOVENT BIO (01801) 42.35 +4.44
EVEREST MED-B (01952) 29.85 +1.53
WUXI BIO (02269) 18.20 -2.15
BEIGENE (06160) 101.40 -0.39
SKB BIO-B (06990) 132.90 +12.91
AKESO (09926) 50.30 +4.79
REMEGEN (09995) 26.85 +11.88
---------------------------------------------
(ed)